The FDA’s recent decision to restrict access to Covid-19 boosters for Americans under 65 marks a significant shift in pandemic policy. As health authorities adjust their approach, the focus turns to the evolving landscape of vaccine strategy and public health.
Recent changes have lifted some restrictions on communications from the CDC and other federal health agencies, allowing them to engage more openly. However, many channels remain blocked, reflecting ongoing tensions around public health messaging.